
Shareholding25 Sept 2026, 11:44 am
India Business Excellence Fund III Sells 30 Lakh Molbio Diagnostics Shares
AI Summary
India Business Excellence Fund III, a scheme of Business Excellence Trust III, has sold an aggregate of 30,00,000 equity shares of Molbio Diagnostics Limited. The transaction, which occurred on September 23, 2026, resulted in the fund's holding decreasing from 11.52% to 11.22% of the total equity share capital. This sale triggered the disclosure requirements under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The sale was conducted via the open market.
Key Highlights
- India Business Excellence Fund III sold 30,00,000 Molbio Diagnostics shares.
- Holding decreased from 11.52% to 11.22% post-sale.
- Sale occurred on September 23, 2026, via open market.
- Disclosure filed under SEBI SAST Regulations 29(2).
Price Impact
More from MOLBIO